Ryan Specialty Holdings (NYSE: RYAN) awards 22,920 options to EVP
Rhea-AI Filing Summary
Ryan Specialty Holdings reported that EVP & CHRO Michael Conklin received a grant of 22,920 Executive Chairman stock options on August 4, 2026. The options have a $43.63 exercise price, expire on August 4, 2036, and vest in three equal installments on October 1, 2029, 2030 and 2031. Following the award, he holds 22,920 derivative securities directly. The options are exercisable on a 1-for-1 basis into Class A common stock, and the grant was approved by the compensation and governance committee for purposes of Rule 16(b)(3).
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Conklin Michael
Role
EVP & CHRO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Executive Chairman Stock Option F1 | 22,920 | $0.00 | $0.00 |
Holdings After Transaction:
Executive Chairman Stock Option — 22,920 shares (Direct)
Footnotes (1)
- F1. The stock options vest in equal amounts on October 1, 2029, 2030 and 2031 and are exercisable on a 1-for-1 basis for shares of Class A common stock, par value $0.001 per share, of the Issuer. Such grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).
Key Figures
Stock options granted: 22,920 options
Exercise price: $43.63 per share
Expiration date: August 4, 2036
+3 more
6 metrics
Stock options granted
22,920 options
Executive Chairman Stock Option grant to Michael Conklin on August 4, 2026
Exercise price
$43.63 per share
Conversion or exercise price of the granted stock options
Expiration date
August 4, 2036
Expiration of Executive Chairman Stock Option grant
Underlying shares
22,920 shares
Underlying Class A common stock issuable on a 1-for-1 basis
Vesting dates
Oct 1, 2029; Oct 1, 2030; Oct 1, 2031
Three equal vesting installments for the stock options
Holdings after grant
22,920 derivative securities
Total options held directly by Michael Conklin after this transaction
Key Terms
Executive Chairman Stock Option, Class A common stock, Rule 16(b)(3)
3 terms
Executive Chairman Stock Option financial
"An Executive Chairman Stock Option was granted to Michael Conklin as a derivative security."
Class A common stock financial
"The options are exercisable on a 1-for-1 basis for shares of Class A common stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Rule 16(b)(3) regulatory
"The grant was approved by the compensation and governance committee for purposes of Rule 16(b)(3)."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did RYAN report for Michael Conklin?
RYAN reported that EVP & CHRO Michael Conklin received a grant of 22,920 stock options on August 4, 2026. These Executive Chairman stock options are exercisable into Class A common stock and represent a compensation-related award rather than an open-market purchase or sale.
What is the exercise price of Michael Conklin’s new RYAN options?
The newly granted options to Michael Conklin carry an exercise price of $43.63 per share. They are exercisable on a 1-for-1 basis into Class A common stock, providing potential future equity exposure if the share price exceeds this exercise price.
How many RYAN options does Michael Conklin hold after this Form 4?
After this reported transaction, Michael Conklin holds 22,920 derivative securities related to Ryan Specialty Holdings. These options were all acquired in this single grant and are held directly, subject to the vesting schedule and expiration terms disclosed.
When do Michael Conklin’s new RYAN stock options vest?
The granted stock options vest in three equal installments on October 1, 2029, 2030 and 2031. This means one-third of the options becomes exercisable on each of those dates, aligning the long-term incentive with multi-year service and performance horizons.
When do the RYAN stock options granted to Michael Conklin expire?
The Executive Chairman stock options granted to Michael Conklin expire on August 4, 2036. After that date, any unexercised portion of the 22,920 options will lapse, limiting the exercise window to roughly a decade after the original grant date.
Were Michael Conklin’s RYAN options approved by a board committee?
Yes. The filing states the grant was approved by the compensation and governance committee of Ryan Specialty Holdings’ board for purposes of Rule 16(b)(3). This committee-level approval is referenced directly in the transaction’s footnote disclosure.